Age effect of antipsychotic medications on the risk of sudden cardiac death in patients with schizophrenia: A nationwide case-crossover study.

Psychiatry and Clinical Neurosciences
Pao-Huan ChenChian-Jue Kuo

Abstract

Research regarding the effects of age in patients with schizophrenia taking antipsychotics on the risk of sudden cardiac death is lacking. We determined the effect of patient age on the association between exposure to antipsychotics and the risk of sudden cardiac death in a nationwide schizophrenia cohort. From the Taiwan National Health Insurance Research Database and Department of Health Death Certification System, data of 1836 patients with schizophrenia who had experienced sudden cardiac death between 2000 and 2016 were included. A case-crossover design by using a 14-day window was applied, and subgroup analyses were performed by stratifying patients into three age subgroups (<45, 45-65, and >65 years) to assess the effect of age on the risk of sudden cardiac death in patients taking antipsychotics. No association between exposure to antipsychotic agents and sudden cardiac death risk was found in patients aged >65 years who were characterized by a high burden of medical illnesses. However, zotepine significantly increased the risk of sudden cardiac death in patients aged <45 years (adjusted relative risk [RR] = 2.68, P = 0.046). Flupentixol (adjusted RR = 5.30, P = 0.004) and risperidone (adjusted RR = 1.68, P = 0.01) signi...Continue Reading

References

Oct 31, 2001·Circulation·Z J ZhengG A Mensah
Nov 3, 2001·The American Journal of Psychiatry·A H Glassman, J T Bigger
Mar 17, 2004·Journal of Clinical Epidemiology·S M J M StrausM C J M Sturkenboom
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Nov 6, 2007·Methods and Findings in Experimental and Clinical Pharmacology·J S Silvestre, J R Prous
Sep 17, 2008·Journal of Clinical Psychopharmacology·Yu-Chung LinHsien-Yuan Lane
Jan 16, 2009·The New England Journal of Medicine·Wayne A RayC Michael Stein
Nov 18, 2009·British Journal of Clinical Pharmacology·Kate JollyMichael J S Langman
Jan 19, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yuji OzekiHiroshi Kunugi
Mar 17, 2011·The American Journal of Psychiatry·Chi-Shin WuSusan Shur-Fen Gau
Jun 16, 2011·The Journal of Clinical Psychiatry·Peter ManuChristoph U Correll
Mar 27, 2012·Psychiatry and Clinical Neurosciences·Yutaro SuzukiToshiyuki Someya
Jan 16, 2013·The American Journal of Psychiatry·Casey CrumpJan Sundquist
Sep 14, 2013·Schizophrenia Research·Joanna SweetingChristopher Semsarian
Mar 13, 2014·Circulation. Arrhythmia and Electrophysiology·Eric C SteckerSumeet S Chugh
Apr 8, 2014·Schizophrenia Research·Petru IfteniPeter Manu
Mar 31, 2015·Current Problems in Cardiology·Vikas P KuriachanL Brent Mitchell
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellMarc De Hert
Jul 27, 2015·Schizophrenia Research·Ping-Yi HouChian-Jue Kuo
Aug 15, 2015·Clinical Pharmacology and Therapeutics·F SalvoUNKNOWN Investigators of the ARITMO Consortium
Oct 29, 2015·JAMA Psychiatry·Mark OlfsonT Scott Stroup
Jan 28, 2017·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Nancy H LiuShekhar Saxena
Mar 9, 2018·Current Opinion in Psychiatry·Kevin J LiLynn E Delisi
Oct 9, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Pao-Huan ChenChian-Jue Kuo
Nov 7, 2018·Statistics in Medicine·Sai DharmarajanRima Izem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here